Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
✓ The present study was undertaken to determine if estrogens protect female rats from the neurodegenerative effects of middle cerebral artery (MCA) occlusion. The rats were ovariectomized and 7 or 8 days later various estrogen preparations were administered before or after MCA occlusion. Pretreatment with 17β-estradiol (17β-E2) or a brain-targeted 17β-E2 chemical delivery system (CDS) decreased mortality from 65% in ovariectomized rats to 22% in 17β-E2—treated and 16% in 17β-E2 CDS—treated rats. This marked reduction in mortality was accompanied by a reduction in the ischemic area of the brain from 25.6 ± 5.7% in the ovariectomized rats to 9.8 ± 4% and 9.1 ± 4.2% in the 17β-E2—implanted and the 17β-E2 CDS—treated rats, respectively. Similarly, pretreatment with the presumed inactive estrogen, 17α-estradiol, reduced mortality from 36 to 0% and reduced the ischemic area by 55 to 81%. When administered 40 or 90 minutes after MCA occlusion, 17β-E2 CDS reduced the area of ischemia by 45 to 90% or 31%, respectively. In summary, the present study provides the first evidence that estrogens exert neuroprotective effects in an animal model of ischemia and suggests that estrogens may be a useful therapy to protect neurons against the neurodegenerative effects of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,314
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
Bederson, J. B., Pitts, L. H., Germano, S. M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. M. (1986) · Stroke · doi:10.1161/01.str.17.6.1304 · Cited by 1,277
Goodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66051836.x · Cited by 830
Postmenopausal Estrogen Therapy and Cardiovascular Disease
(1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261012 · Cited by 703
Rodent models of cerebral ischemia.
Ginsberg, M. D., & Busto, R. (1989) · Stroke · doi:10.1161/01.str.20.12.1627 · Cited by 659
17-β Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death in Vitro
Behl, C., Widmann, M., Trapp, T., & Holsboer, F. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2647 · Cited by 608
Singh, M., Meyer, E. M., Millard, W. J., & Simpkins, J. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)91694-2 · Cited by 477
Self-citation
Cited by
Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00025-3 · Cited by 938
ROOF, R. L., & HALL, E. D. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.367 · Cited by 655
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 647
Estradiol Protects against Ischemic Injury
Dubal, D. B., Kashon, M. L., Pettigrew, L. C., Ren, J. M., Finklestein, S. P., Rau, S. W., & Wise, P. M. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00012 · Cited by 554
Toran-Allerand, C. D., Guan, X., MacLusky, N. J., Horvath, T. L., Diano, S., Singh, M., Connolly, E. S., Nethrapalli, I. S., & Tinnikov, A. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08391.2002 · Cited by 548
Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury
Dubal, D. B., Zhu, H., Yu, J., Rau, S. W., Shughrue, P. J., Merchenthaler, I., Kindy, M. S., & Wise, P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1952 · Cited by 547
Sex differences in cognitive impairment and Alzheimer’s disease
Li, R., & Singh, M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.002 · Cited by 527
Neuroprotective effects of estrogens: potential mechanisms of action
Green, P. S., & Simpkins, J. W. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00017-4 · Cited by 523
“bE2 may also reduce lesion size when administered after onset of the ischemic episode [109,146,149] (Table 2).”
BackgroundInfluentialSelf-citationEstradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors
Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., & Wise, P. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06385.1999 · Cited by 449
Novel Mechanisms of Estrogen Action in the Brain: New Players in an Old Story
Toran-Allerand, C. D., Singh, M., & Sétáló, G. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0177 · Cited by 427
Estrogen as a Neuroprotectant in Stroke
Hurn, P. D., & Macrae, I. M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200004000-00001 · Cited by 401
Non-genomic actions of sex steroid hormones
Simoncini, T., & Genazzani, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480281 · Cited by 368
Non-genomic actions of estrogens and their interaction with genomic actions in the brain
Vasudevan, N., & Pfaff, D. W. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.003 · Cited by 343
Neuroprotective Effects of Female Gonadal Steroids in Reproductively Senescent Female Rats
Alkayed, N. J., Murphy, S. J., Traystman, R. J., & Hurn, P. D. (2000) · Stroke · doi:10.1161/01.str.31.1.161 · Cited by 333
Estrogen and ischemic neuroprotection: an integrated view
McCullough, L. D., & Hurn, P. D. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00076-6 · Cited by 317
Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
Murphy, S. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<1::aid-glia1>3.0.co;2-n · Cited by 314
17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals
Rusa, R., Alkayed, N. J., Crain, B. J., Traystman, R. J., Kimes, A. S., London, E. D., Klaus, J. A., & Hurn, P. D. (1999) · Stroke · doi:10.1161/01.str.30.8.1665 · Cited by 304
Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition
Maki, P. M., & Resnick, S. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00123-8 · Cited by 289
de la Torre, J. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00111-1 · Cited by 284
Brain aromatase is neuroprotective
Azcoitia, I., Sierra, A., Veiga, S., Honda, S., Harada, N., & Garcia‐Segura, L. M. (2001) · Journal of Neurobiology · doi:10.1002/neu.1038 · Cited by 273
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Minireview: Neuroprotective Effects of Estrogen--New Insights into Mechanisms of Action
Wise, P. M. (2001) · Endocrinology · doi:10.1210/en.142.3.969 · Cited by 259
McCarthy, M., & Raval, A. P. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01998-9 · Cited by 254
Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles
Vasudevan, N., & Pfaff, D. W. (2007) · Endocrine Reviews · doi:10.1210/er.2005-0021 · Cited by 231
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model
Selvamani, A., Sathyan, P., Miranda, R. C., & Sohrabji, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032662 · Cited by 217
“Estrogen is also neuroprotective for stroke [24–26] and IGF-1 and estrogen”
BackgroundSex differences in the brain: Implications for behavioral and biomedical research
Choleris, E., Galea, L. A. M., Sohrabji, F., & Frick, K. M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.005 · Cited by 214
“…that ovarian estrogens improve stroke outcomes, which is supported by a large number of studies showing that 17β-estradiol, the inactive stereoisomer 17-α estradiol (Simpkins et al., 1997), or conjugated equine estrogens (McCullough et al., 2001) reduce infarct volume in ovariectomized rodents.”
BackgroundSingh, M. (2001) · Endocrine · doi:10.1385/endo:14:3:407 · Cited by 194
Increased β-secretase activity and expression in rats following transient cerebral ischemia
Wen, Y., Onyewuchi, O., Yang, S., Liu, R., & Simpkins, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2003.09.086 · Cited by 188
Self-citationHogue, C. W., Barzilai, B., Pieper, K. S., Coombs, L. P., DeLong, E. R., Kouchoukos, N. T., & Dávila-Román, V. G. (2001) · Circulation · doi:10.1161/01.cir.103.17.2133 · Cited by 187
Cellular Functions of the Plasma Membrane Estrogen Receptor
Levin, E. R. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00192-7 · Cited by 179
Dubal, D. B., Rau, S. W., Shughrue, P. J., Zhu, H., Yu, J., Cashion, A. B., Suzuki, S., Gerhold, L. M., Bottner, M. B., Dubal, S. B., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1177 · Cited by 174
“In contrast, treatment with pharmacological doses of estradiol, either acutely or even after injury, suggests that estradiol can act through rapid, nongenomic actions, such as N-methyl-d-aspartate receptor modulation and lipid peroxidation reduction to decrease injury in neural tissue (21, 24, 83).”
BackgroundYang, L.-C., Zhang, Q.-G., Zhou, C.-F., Yang, F., Zhang, Y.-D., Wang, R.-M., & Brann, D. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009851 · Cited by 163
“rats and gerbils, and in male rats and gerbils [1,6,7,8,9,10].”
BackgroundSelf-citationCdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats
Wen, Y., Yang, S.-H., Liu, R., Perez, E. J., Brun-Zinkernagel, A. M., Koulen, P., & Simpkins, J. W. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.011 · Cited by 162
“In order to avoid fluctuations of estrogens, which is neuroprotective [39,40], all animals received bilateral ovariectomy.”
Self-citationTurtzo, L. C., & McCullough, L. D. (2008) · Cerebrovascular Diseases · doi:10.1159/000155983 · Cited by 158
“One major issue is the age of the women given estrogen. In laboratory models estrogen is potently neuroprotective when given immediately after menopause [”
BackgroundWilson, M. E., Westberry, J. M., & Trout, A. L. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.08.004 · Cited by 85
Stary, C. M., Xu, L., Li, L., Sun, X., Ouyang, Y.-B., Xiong, X., Zhao, J., & Giffard, R. G. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.05.004 · Cited by 49
“Although a full understanding of the mechanisms underlying sex differences in stroke remains to be determined, the ovarian hormone estrogen is known to play a role in ischemic protection (Manwani et al., 2015; Simpkins et al., 1997).”
Metadata
- Authors
- Simpkins, J. W., Rajakumar, G., Zhang, Y.-Q., Simpkins, C. E., Greenwald, D., Yu, C. J., Bodor, N., & Day, A. L.
- Venue
- Journal of Neurosurgery
- Published
- 1997-11
- Volume
- 87
- Issue
- 5
- Pages
- 724-730
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2159984609
- Cited by
- 509
- References
- 32
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.